{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:18:13Z","timestamp":1772792293946,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ghir.2010.10.005","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T04:36:18Z","timestamp":1290227778000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: Results of the German KIMS database"],"prefix":"10.1016","volume":"21","author":[{"given":"Christin","family":"Spielhagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schwahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"Moock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ko\u0142towska-H\u00e4ggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Wallaschofski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2010.10.005_bb0005","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.005_bb0015","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.005_bb0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF01797616","article-title":"Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?","volume":"69","author":"W\u00fcster","year":"1991","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.ghir.2010.10.005_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","article-title":"Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.005_bb0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"issue":"Suppl 4","key":"10.1016\/j.ghir.2010.10.005_bb0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000181584","article-title":"Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency","volume":"33","author":"McGauley","year":"1990","journal-title":"Horm Res"},{"key":"10.1016\/j.ghir.2010.10.005_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","article-title":"Decreased psychological well-being in adult patients with growth hormone deficiency","volume":"40","author":"Rosen","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0050","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10years of recombinant human growth hormone (GH) in adult GH-deficient patients","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ghir.2003.12.001","article-title":"Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption","volume":"14","author":"Svensson","year":"2004","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ghir.2010.10.005_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.1997.2801076.x","article-title":"Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3years","volume":"47","author":"Wallymahmed","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ghir.2010.10.005_bb0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","article-title":"Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial","volume":"125","author":"Baum","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ghir.2010.10.005_bb0070","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"G\u00f6therstr\u00f6m","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0075","first-page":"2865","article-title":"Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0080","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/ajcn\/61.6.1186","article-title":"Comparison of measurements of body composition by total body potassium, bioimpedance analysis, and dual-energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment","volume":"61","author":"Beshyah","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ghir.2010.10.005_bb0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0090","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1210\/jc.2002-020901","article-title":"Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength","volume":"88","author":"Svensson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","article-title":"Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults","volume":"48","author":"al-Shoumer","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0100","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1210\/jc.2007-2810","article-title":"Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency","volume":"93","author":"Colao","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0105","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults","volume":"87","author":"Svensson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0110","first-page":"379","article-title":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0120","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0125","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1210\/jc.2007-0458","article-title":"Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone","volume":"92","author":"Holmer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0130","first-page":"3762","article-title":"Effects of 7years of growth hormone replacement therapy in hypopituitary adults","volume":"85","author":"Chrisoulidou","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02176","article-title":"Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?","volume":"155","author":"Koltowska-H\u00e4ggstr\u00f6m","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0140","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","article-title":"Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study","volume":"86","author":"Koranyi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0145","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1210\/jc.2004-0832","article-title":"The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy","volume":"90","author":"Mukherjee","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0150","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)","volume":"89","author":"Rosilio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1530\/eje.1.02283","article-title":"Sustained effects of recombinant GH replacement after 7years of treatment in adults with GH deficiency","volume":"155","author":"van der Klaauw","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2002.01608.x","article-title":"The effect of long-term untreated growth hormone deficiency (GHD) and 9years of GH replacement on the quality of life (QoL) of GH-deficient adults","volume":"57","author":"Gilchrist","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0165","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2006-1487","article-title":"A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults","volume":"92","author":"G\u00f6therstr\u00f6m","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0170","first-page":"1600","article-title":"Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status\u20143-year results from the HypoCCS Database","volume":"87","author":"Attanasio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.2003.01799.x","article-title":"Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects","volume":"59","author":"Malik","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.1998.00462.x","article-title":"Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency","volume":"48","author":"Wiren","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1037\/1082-989X.2.1.64","article-title":"Application of random-effects pattern-mixture models for missing data in longitudinal studies","volume":"2","author":"Hedeker","year":"1997","journal-title":"Psychol Meth"},{"key":"10.1016\/j.ghir.2010.10.005_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","article-title":"The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency","volume":"8","author":"McKenna","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ghir.2010.10.005_bb0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.ghir.2010.10.005_bb0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0205","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/clinchem\/22.10.1627","article-title":"Cholesterol oxidase-based determination, by continuous-flow analysis, of total and free cholesterol in serum","volume":"22","author":"Lie","year":"1976","journal-title":"Clin Chem"},{"key":"10.1016\/j.ghir.2010.10.005_bb0210","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/clinchem\/23.5.882","article-title":"Cholesterol determination in high-density lipoproteins separated by three different methods","volume":"23","author":"Lopes-Virella","year":"1977","journal-title":"Clin Chem"},{"key":"10.1016\/j.ghir.2010.10.005_bb0215","series-title":"Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence","author":"Singer","year":"2003"},{"key":"10.1016\/j.ghir.2010.10.005_bb0220","unstructured":"S. Rabe-Hesketh, A. Skrondal, A. Pickles. GLLAMM Manual."},{"key":"10.1016\/j.ghir.2010.10.005_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-08-0738","article-title":"Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania","volume":"160","author":"Moock","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2265.1997.3041112.x","article-title":"Two years of replacement therapy in adults with growth hormone deficiency","volume":"47","author":"Verhelst","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ghir.2010.10.005_bb0235","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0240","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women","volume":"82","author":"Burman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ghir.2006.11.002","article-title":"Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response","volume":"17","author":"Svensson","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ghir.2010.10.005_bb0250","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2265.2006.02676.x","article-title":"Modulation of growth hormone action by sex steroids","volume":"65","author":"Meinhardt","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0255","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1210\/jc.2006-0887","article-title":"Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency","volume":"91","author":"Franco","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.278.5337.419","article-title":"The endocrinology of aging","volume":"278","author":"Lamberts","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ghir.2010.10.005_bb0265","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.10.005_bb0270","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2010.10.005_bb0275","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1530\/EJE-09-0287","article-title":"Safety aspects of GH replacement","volume":"161","author":"Svensson","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ghir.2010.10.005_bb0280","first-page":"302","article-title":"The risk of diabetes mellitus in hypopituitary patients on growth hormone substitution","volume":"12","author":"Bengtsson","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ghir.2010.10.005_bb0285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2009-1326","article-title":"Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement","volume":"95","author":"Attanasio","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637410001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637410001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:46:22Z","timestamp":1761086782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637410001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1096637410001243"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2010.10.005","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: Results of the German KIMS database","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2010.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Growth Hormone Research Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}